# BPC-157 & TB-500 - Two research peptides - BPC-157 and TB-500 - studied in tissue-repair research, supplied as one vial containing a 10 mg blend. BPC-157 & TB-500 research-use-only blend - one freeze-dried 10 mg vial, catalog lot details, dispatched from Perth. ## At a glance | | | | --- | --- | | Compound | BPC-157 & TB-500 | | Descriptor | Two-peptide research blend | | Current certificate | Not verified for listed lot | | Storage | 2-8 C | | Format | Freeze-dried powder | | Availability | Out of stock | | Lot | BPTB-2506 | ## Sizes and pricing (AUD) | | | | --- | --- | | 10 mg | $119 AUD | ## Certificate status Matching current certificate unavailable. No verified report matches the listed compound, lot and amount. Historical sample report: BPC-157 & TB-500, 10 mg blend, lot FL20260410-BPC-TB-5. Test: Heavy metals analysis. This report does not verify the listed item or lot; a document mismatch does not establish the physical product's contents. ## What's in the BPC-157 + TB-500 set? BPC-157 and TB-500 are supplied as a 10 mg blend in one vial. Pack options count vials. BPC-157 is a 15-amino-acid peptide based on a partial sequence of a protective protein in gastric juice. TB-500 is a seven-amino-acid fragment of the protein thymosin beta-4 (not the full protein). Both are studied mostly in cells and animals, with no completed human trials. One 2026 rat study (Biçer et al., Joint Diseases and Related Surgery) included both, and this set makes no combined claim. ## Specifications One vial containing a 10 mg blend of two compounds. BPC-157 is identified by its sequence GEPPPGKPADDAGLV; TB-500 by the Ac-LKKTETQ fragment. A matching current certificate is unavailable; historical reports cover only their named samples. | | | | --- | --- | | Compound A | BPC-157 | | BPC-157 sequence | GEPPPGKPADDAGLV (15 amino acids) | | BPC-157 CAS | 137525-51-0 (free peptide) | | Compound B | TB-500 | | TB-500 sequence | Ac-LKKTETQ (fragment of thymosin beta-4) | | Format | One vial, 10 mg blend | | Lot | BPTB-2506 | ## What the research looks at BPC-157 is studied in rodent and cell models of gut, tendon and blood-vessel repair. TB-500 is studied - mostly as the full thymosin beta-4 protein - for cell movement and tissue repair. The two are supplied together because both sit in tissue-repair research, but they stay separate compounds. One 2026 rat study (Biçer et al.) included both, and this page draws no combined claim from it. Published research and historical sample reports do not establish release status for this listed lot. ## Frequently asked questions ### What is BPC-157 & TB-500 supplied for? BPC-157 & TB-500 is supplied as laboratory research material only. It is 21+ only, not for human consumption, and not for veterinary use. ### Does this page include matching COA information? The product page lists catalog lot, appearance and storage notes for BPC-157 & TB-500. Available original reports are labelled by sample; matching current certification is unavailable where the compound, lot or amount differs. A heavy-metals screen does not measure purity or confirm identity. ### How should the vial be handled after delivery? Follow the label and your laboratory's written procedures. Do not treat a historical sample report as current lot documentation. This page repeats 2-8 C storage guidance and light-protection notes before checkout. ### Why are BPC-157 and TB-500 sold together? BPC-157 and TB-500 are distinct compounds often studied around the same topic - tissue repair. One unit is one vial containing a 10 mg blend. Pack options count vials; each compound has its own research history. ### Do they work better together? We make no such claim. One 2026 rat study (Biçer et al.) included both, and this page draws no combined effect from it. They're supplied as a 10 mg blend in one vial; matching current certification is unverified. ### Can this be used outside a lab? No. Both are supplied for laboratory research only, 21+ only, and not for human or animal consumption. Neither is approved by any medicines regulator. ## References - Chang 2011 (BPC-157): Chang CH et al. J Appl Physiol. 2011;110(3):774-780. Rat and cell tendon-healing study. DOI: 10.1152/japplphysiol.00945.2010 - Van Troys 1996 (TB-500): Van Troys M et al. EMBO J. 1996;15(2):201-210. Actin-binding region of thymosin beta-4. DOI: 10.1002/j.1460-2075.1996.tb00350.x - Esposito 2012 (TB-500): Esposito S et al. Drug Test Anal. 2012;4(9):733-738. Characterisation of the Ac-LKKTETQ fragment. DOI: 10.1002/dta.1402 This summary is for scientific and educational context only. It is not preparation guidance, administration guidance, or a statement about use in people or animals. --- Canonical page: https://www.formlaboratories.com/shop/bpc-157-tb-500 Form Laboratories - Perth-based research-use-only peptide supplier, shipping Australia-wide. - Site guide for agents: https://www.formlaboratories.com/llms.txt - Sitemap: https://www.formlaboratories.com/sitemap.xml - Full catalogue: https://www.formlaboratories.com/shop - Contact: hello@formlaboratories.com All materials are supplied for laboratory research use only - not for human or veterinary use, and nothing on this site is medical advice.